Drug Manufacturers—General Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2166 |  MAZE Maze Therapeutics, Inc. - Common Stock | 25.88 USD | -1.41% | -4.43% | +6.68% | -42.53% | 1.44 B USD | ||
| 2169 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 29.85 USD | -3.27% | -10.44% | -31.14% | +13.97% | 1.43 B USD | ||
| 2823 |  CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 USD | +4.67% | -2.49% | -28.14% | +15.93% | 524.47 M USD | ||
| 3004 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 7.50 USD | -0.53% | -0.66% | -29.38% | -56.01% | 406.24 M USD | ||
| 3388 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 11.99 USD | -0.25% | -7.77% | -15.98% | -22.94% | 253.26 M USD | ||
| 3397 |  UPB Upstream Bio, Inc. - Common Stock | 4.55 USD | -1.30% | -6.76% | -22.35% | -77.02% | 249.21 M USD | ||
| 3424 |  QTTB Q32 Bio Inc. - Common Stock | 8.09 USD | +1.25% | -3.11% | -26.45% | +129.83% | 240.83 M USD | ||
| 3863 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.00 USD | -4.31% | -2.44% | -2.91% | -95.56% | 99.69 M USD | ||
| 3886 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 2.30 USD | -2.13% | -10.51% | -32.15% | -6.12% | 93.14 M USD | ||
| 3965 |  PTHS Pelthos Therapeutics Inc. Common Stock | 20.80 USD | -2.58% | +1.41% | -9.88% | -14.79% | 79.63 M USD | ||
| 3990 |  OSTX OS Therapies Incorporated Common Stock | 1.62 USD | +5.88% | -0.61% | -12.90% | +40.87% | 74.72 M USD | ||
| 4178 |  EXOZ eXoZymes Inc. - Common Stock | 5.33 USD | -3.79% | -7.47% | -13.75% | -45.05% | 49.47 M USD | ||
| 4183 |  VBIO Valion Bio, Inc. - Common stock | 2.21 USD | +0.91% | -13.33% | -7.14% | +84.17% | 49.04 M USD | ||
| 4193 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.41 USD | -1.40% | -7.84% | -27.32% | -53.00% | 47.93 M USD | ||
| 4312 |  IBO Impact BioMedical, Inc. Common Stock | 4.12 USD | -9.25% | -21.82% | +758.33% | +836.36% | 35.20 M USD | ||
| 4378 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.70 USD | -1.41% | -4.11% | -11.39% | -48.15% | 29.42 M USD | ||
| 4415 |  SCLX Scilex Holding Company - Common Stock | 2.96 USD | -15.19% | -33.03% | -42.97% | -63.59% | 25.14 M USD | ||
| 4734 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 USD | -22.09% | +32.44% | +136.09% | +314.50% | 8.19 M USD | ||
| 4786 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.10 USD | -37.50% | -37.50% | -41.18% | -91.53% | 6.32 M USD | ||
| 4829 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.64 USD | +1.59% | -17.95% | -63.22% | -83.42% | 5.24 M USD |
Noticias Drug Manufacturers—General Stocks
SOPHiA GENETICS y Myriad Genetics colaboran para avanzar en una nueva tecnología de puntuación de inestabilidad genómica específica para el cáncer de próstata
Cantor Fitzgerald eleva el precio objetivo de Pfizer por sus perspectivas
Northern Discovery adquirirá el proyecto de cobre y oro Cibola en Columbia Británica
Cantor Fitzgerald rebaja el precio objetivo de Bristol-Myers Squibb a 53 dólares
Cantor Fitzgerald eleva el precio objetivo de Amgen por la solidez de su cartera
Cantor Fitzgerald eleva el precio objetivo de Merck ante las perspectivas para 2027
Cantor Fitzgerald eleva el precio objetivo de Eli Lilly por tendencias de demanda
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
 MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
 GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
 CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |